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ABSTRACT

The purpose of this project was to improve how clinicians communicate to
patients about cardiovascular medications to the end of improving adherence and
optimizing cardiac outcomes. In this project, clinician knowledge and communication
confidence with regard to patient education and medication adherence was assessed using
a pre-survey. An educational module to increase awareness and improve clinician-patient
communication using the teach-back method was provided to inpatient cardiology
clinicians consisting of registered nurses and physicians. The goal of the module and
communication tool was to improve patient understanding of cardio-protective
medications and increase the motivation to adhere to a chronic illness medication
regimen. Knowledge and confidence were re-evaluated following the educational session
using a post-survey.
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CHAPTER I: INTRODUCTION
“Drugs don’t work in patients that don’t take them” - C. Everett Koop, MD

Heart disease is the leading cause of death in the United States. More specifically,
coronary heart disease is the most common type of heart disease. Someone has a
myocardial infarction (MI) every 43 seconds and dies from a MI every minute (CDC,
n.d.). Adherence to a core set of cardiovascular medications is the foundation for
coronary heart disease prevention and management (Anderson et al., 2013).
Nonadherence to the core medications used for secondary prevention is extremely
prevalent and is associated with an increased risk of morbidity and mortality.
Interventions to improve medication adherence have been called the next frontier in
quality improvement (Ho, Bryson, & Rumsfeld, 2009).
Adherence is the ability to carry out a health behavior and is an important
predictor of health outcomes. Adherence to medications is defined as taking a medication
as prescribed over the period of time for which it is prescribed (AHRQ, 2011). Studies
have consistently demonstrated that roughly 1 in 4 patients treated for acute myocardial
infarction fail to fill their discharge prescriptions by 1 week. Of those that do fill their
prescriptions, less than half will adhere to the prescribed regimen by 2 years of their
hospitalization (Ho et al., 2009).
The causes of nonadherence are multifactorial. The reasons can be broadly
grouped into 3 categories: communication barriers, motivation, and socioeconomic
(figure 1). These categories often overlap in areas such as complex medication regimens
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and instructional requirements (Baroletti & Dell’Orfano, 2010). The fact that there is
significant overlap within the causes of nonadherence creates an opportunity for targeted
effective communication between clinicians and patients to overcome some of these
barriers.

Figure 1. Causes of medication nonadherence (Baroletti & Dell’Orfano, 2010)

Purpose of the Project
The purpose of this project is to improve how clinicians communicate and educate
about cardiovascular medications to the end of improving adherence in patients
hospitalized for coronary artery disease. To improve clinician-patient communication, a
quality improvement education module directed at inpatient hospital clinicians who
initiate medications to patients treated for cardiovascular disease was implemented. The
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educational module instructed clinicians in the teach-back method, an evidence based
health literacy intervention that improves patient-provider communication and is proven
to improve medication adherence (Dinh, Bonner, Clark, Ramsbotham, & Hines, 2016;
Petrilla, Benner, Battleman, Tierce, & Hazard, 2005).

Theoretical Framework
The theoretical framework in designing and implementing this project was based
on the tenets of andragogy. Andragogy is a theoretical model of adult learning promoted
by Malcolm Knowles. This adult learning theory provides a model to identify how adults
learn, compared to how children learn or pedagogy (Knowles, 1984). The principles
captured by Knowles’ theory not only offers the opportunity to improve the teaching of
the in-service module to clinicians, but it also allows for the incorporation of principles
within the content of the educational material to facilitate the learning of the end target
audience, the patients. In other words, the principles of andragogy facilitate the goal of
teaching the teachers.
Knowles’ theory of andragogy incorporates five tenets of adult learning: readiness
to learn, motivation to learn, the learning experience, self-concept regarding learning, and
the orientation to learning. These five assumptions form a framework for educational
content and delivery development by creating awareness that adult learners are ready and
motivated to learn when knowledge can be internalized and applicable to real life
problems identified within their developmental and changing social roles. Adult learners
have a need to know why they need new knowledge and learn best when real life
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experiences can be incorporated into the learning through self-discovery (Knowles,
1984).
The tenets of andragogy are relevant to teaching clinicians in methods to
communicate and educate patients because the adult learner approaches learning as
problem solving. Knowledge is adopted when the content being conveyed is of
immediate value. By incorporating role-playing, self-evaluation, simulations, and case
studies into the instruction of this project, adult learners are better positioned to take
ownership of the material while promoting autonomy.

Core Competencies of Advanced Practice Nursing
The National Organization of Nurse Practitioner Faculties (NONPF) establishes
the nurse practitioner core competencies. The NONPF core competencies this project
incorporates include leadership, practice inquiry, scientific foundation, health delivery
system, and quality (Thomas et al., 2012).
This project synthesized the current research regarding nonadherence to
cardiovascular medications and interventions to address the problem. In developing the
project, research was critically analyzed to gain a better understanding of the reasons for
nonadherence and to identify non-complex, cost-effective evidence-based interventions.
The research was then rendered into a clinically relevant project developed to improve
clinician-patient communication. A clinical practice quality improvement educational
module was developed and implemented as an in-service to empower a group of interprofessional clinicians to educate patients more effectively. Knowledge, skills, and
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confidence regarding nonadherence and medication education were quantified with the
support of a pre-and post survey.
The development and implementation of this project provided the opportunity to
cultivate professional and clinical leadership consistent with the NONPF core
competencies. Leadership competencies regarding collaboration, cost effective quality
improvement, and practice advancement were integral to the project. By engaging and
educating clinicians about the importance and prevalence of nonadherence and
disseminating evidence based communication skills to improve patient and health system
outcomes, the core competencies outlined by NONPF are clearly reflected.
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CHAPTER II: LITERATURE REVIEW
Searches were conducted in PubMed, CINAHL, MEDLINE, Cochrane library,
and Google Scholar databases. Search terms were combined by AND or OR and included
but were not limited to: medication, adherence, compliance, observance, coronary, heart,
disease, intervention, education, teach-back, communication, acute, myocardial,
infarction, mortality, morbidity, health, literacy. Reference lists of included articles were
also searched for further potential references.
Adherence to a core set of cardiovascular medications is the foundation for
coronary heart disease prevention and management. The evidence based guidelines from
the American Heart Association and the American College of Cardiology Foundation for
the management of post acute myocardial infarction (MI) emphasizes the importance of
medical therapy to reduce the risk of subsequent ischemic events and mortality.
Specifically, aspirin (ASA), beta blockers (BB), and hydroxymethyl glutaryl-coenzyme A
reductase inhibitors (statins) should be continued indefinitely. Depending on patient
specific disease characteristics and interventions, two other medications, a P2T12
receptor inhibitor (ex. clopidogrel, ticagrelor, prasugrel), and angiotensin-converting
enzyme inhibitors (ACEI) are also considered to be integral components of core therapy
to reduce morbidity and mortality, level of evidence A or B (Anderson et al., 2013).
In a study by Ford et al. (2007) to determine the causes for the decrease in deaths
from coronary disease between 1980 and 2000, cardiovascular medications alone were
estimated to account for half of the 50% reduction in mortality over this time period
(Ford et al., 2007).
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The Problem of Core Therapy Nonadherence
The prevalence of medication nonadherence is extensive and well documented.
Jackevicius et al. (2008) conducted a population-based cohort study that included over
4500 post acute MI patients. Their analysis demonstrated that approximately 25% of
acute MI patients fail to fill their discharge prescriptions by 120 days. Primary
nonadherence, not filling prescriptions, was associated with increased 1-year mortality
rate.
Of those that do fill their prescriptions, 50% of the patients will discontinue their
antihypertensive medications within 6 to 12 months, and only approximately 40% will
continue their statin medication by 2 years (figure 2). Long-term and short-term surveys
that assessed self-adherence to cardiovascular medications for secondary prevention
revealed less than 40% of respondents adhering to the combination of ASA, BB, and
statin. Of note, there is a particularly progressive decline in the adherence to BB and
statins (Ho P, Spertus JA, Masoudi FA, & et al, 2006; Newby et al., 2006).
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Figure 2. Adherence to Cardiovascular Medications. (Ho P et al., 2006)

Choudhry et al. (2014) performed a secondary analysis of the MI FREEE trial, a
randomized policy study evaluating adherence improvement, to quantify the relationship
between medication adherence and adverse coronary events. Their results revealed that
patients randomized to full prescription medications had significantly better event-free
survival compared to patients with moderate levels of adherence who demonstrated no
protective benefit. Additionally, their study supported the fact that all guidelinerecommended therapies are necessary and confers substantial benefit, with better
adherence to each drug being associated with reduced risk (Choudhry et al., 2014).
The observational longitudinal study of 31,455 MI survivors over 4 years
performed by Rasmussen et al. (2007) highlights the relationship between adherence and
long-term mortality post acute MI with respect to statins and BBs. The study divided
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patient adherence into categories based on proportion of days covered as determined by
prescription data. Risk of mortality was greatest for low statin adherers compared to
high-adherence subgroup (deaths 261/1071 (24%) vs 2310/14,345 (16%). Adherence to
BBs revealed a similar adherence-mortality-association, however the dose response was
less pronounced as compared to statin therapy (Rasmussen JN et al., 2007). Gehi et al.
(2007) prospectively evaluated the risk of cardiovascular events associated with selfreported medication nonadherence in patients with established CVD. Their results
demonstrated a greater than 2-fold increased rate of cardiovascular events in those
patients self-reporting nonadherence (Gehi AK, Ali S, Na B, & Whooley MA, 2007)
A review by Ho, Bryson, & Rumsfeld (2009) provides insight into the issue of
medication adherence not only as a concern with regard to adverse outcomes and
mortality, but also with regard for the healthcare system and stakeholders. Not initially
filling post MI discharge prescriptions consistently reveals a significant increase in the 1year mortality rate. Estimates are that 33% to 69% of mediation related hospital
admissions are due to non-adherence (Osterberg & Blaschke, 2005). Failing to follow
medication instructions or continue medications increases mortality, new ischemic
events, hospitalizations, and healthcare costs. Nonadherence may be associated with
higher costs of care even when comparing prescription costs to non-prescription medical
costs (Roebuck, Liberman, Gemmill-Toyama, & Brennan, 2011). Additionally,
adherence implications are incorporated into performance measures that reward
longitudinal therapeutic quality care targets and outcomes that require a long-term
clinician-patient partnership (Ho et al., 2009).
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Interventions to Promote Adherence
Although the problem of adherence has been well known and studied for decades,
investigations into interventions that address the educational, behavioral, and
motivational components of adherence have been lacking. A common theme among the
studies that investigate adherence problems for both secondary prevention and primary
prevention is that many of these medications produce no noticeable benefit while
exposing the patient the side effects, costs, and burden of taking medications.
Baroletti & Dell’Orfano (2010) offer insight into solutions that mutually address
communication related and motivational causes of nonadherence. Specifically, they
underscore the opportunity for intensive education at the time of hospitalization due to
the ability to relate the medications to the disease and the availability of clinicians to
sustain a dialogue regarding the medications. They also point out the ability to address
adherence risk factors such as a lack of understanding regarding side effects and adverse
outcomes if discontinued, especially during the crucial post-hospitalization time period
(Baroletti & Dell’Orfano, 2010)
Glynn & Fahey (2011) conducted a systematic review that included 39 studies
that investigated the effects of interventions to improve adherence to long-term
cardiovascular disease medications. Their results identified three core areas that
statistically demonstrated a positive effect on adherence: simplified dosing regimens,
prompting mechanisms, and patient health education. With regard to patient health
education, the authors acknowledge that traditional education methods often fail due to
the complexity of patient adherence behavior. They contend that emphasis on methods
that recognize the patient’s preferences and beliefs need to be incorporated into
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adherence enhancing interventions. Evidence from multiple studies supports the use of
patient-centered approaches to improving adherence, such as using motivational
interviewing. Patient centered education interventions facilitate the ability to understand
the factors affecting mediation adherence such as knowledge level, health beliefs,
perception of risk, and memory (Glynn & Fahey, 2011).
A multifactorial intervention by Lambert-Kerzner et al. (2012) is one of the few
recent studies that have addressed the poor adherence to cardioprotective medication
regimens (BB, ACEi, and Statin). This randomized clinical trial of 253 patients admitted
with acute coronary syndrome (ACS) compared usual care prior to discharge to an
intervention arm that comprised of 4 components: pharmacist-led medical reconciliation
and tailoring, patient education, collaborative care between pharmacists and the primary
care clinician and/or cardiologist, and voice messaging regarding education and
medication refill reminders. The intervention arm of the study produced an 89.3%
adherence rate at 1 year compared to 73.9% adherence in the control group. Although
such complex interventions may not be easily replicated across practice settings, it does
demonstrate the potential for in-hospital interprofessional and provider-patient
partnership in addressing adherence (Lambert-Kerzner et al., 2012).
Santo et al. (2016) performed a systematic review and meta-analysis of
randomized controlled trials (RCT) to assess interventions to improve medication
adherence in coronary disease patients. In their pooled analysis of 10, 706 patients, they
demonstrated that the delivery of an intervention, regardless of its type, improved
medication adherence (OR 1.52; 95% CI 1.25-1.86; p< 0.001). Additionally, their
analysis demonstrated that there were similar results regarding adherence regardless if the
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intervention was complex and multi-component or simple interventions with only one
component (Santo et al., 2016).
The teach-back method, also referred as the ask-tell-ask method, is a health care
related education delivery model that has gained prominence as a method to assess and
reinforce education. The method allows for the assessment of patient recall and
comprehension of new concepts. This creates the opportunity for the clinician to address
the patient’s misunderstandings, and lets the clinician target the learning needs of the
individual, (Figure 3) (Kornburger, Gibson, Sadowski, Maletta, & Klingbeil, 2013;
Schillinger et al., 2003). An important aspect of the teach-back method is that it places
the burden of understanding on the clinician to have explained the information clearly.
This is achieved by using statements such as “I always ask my patients to repeat things
back to me to make sure I have explained them clearly” (Kripalani & Weiss, 2006) . This
patient centered communication technique can have a significant clinical impact when
discharging patients that may be emotionally and physically fatigued at the time of
education.
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Figure 3. teach-back: Closing the Loop (Schillinger et al., 2003).

The teach-back method has demonstrated the ability to improve a variety of health
outcomes, including the discharge process and medication adherence. Patients who have
a good understanding of their discharge transition plan, including knowledge about their
medications and follow-up requirements, are significantly less likely to be readmitted
(Jack et al., 2009). A systematic review published in 2016 investigated the evidence on
using the teach-back method in health education programs for improving adherence and
self-management of people with chronic disease. The systematic analysis included 12
studies that met the inclusion criteria. The analysis demonstrated that the teach-back
method had positive effects on a wide range of health care outcomes including
medication adherence, hospital readmission rates, disease-specific knowledge, and
adherence to diet recommendations (Dinh et al., 2016).
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The literature review of current interventions consistently produces evidence that
support patient-provider partnerships, education, and technology to promote medication
adherence for the prevention of cardiovascular events. Patient education regarding the
purpose of the medications in the context of the disease, the possible side effects, and the
cost of nonadherence have the potential to impact the burden of cardiovascular events on
the patient and the healthcare system. Education based interventions offer the added
benefit of being reproducible and cost effective. The teach-back method in particular
offers the ability to improve both the education outcomes and the clinician-patient
relationship. The teach-back method places emphasis on the patient becoming a
knowledgeable stakeholder in their disease management.
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CHAPTER III: METHODS
Development of Project Material and Implementation
The project provided an educational module, also referred to as an in-service, for
nurses, resident physicians, nurse practitioners, nursing students, and medical students
that have patient encounters. The in-service was delivered on 4 different days to capture
as many participants as possible. A total of twenty-five nurses and residents participated.
The educational module introduced the clinicians to the problem of medication
nonadherence, the concept of teach-back, and strategies to improve adherence. Content
for the module was sourced from Always-use-teach-back training toolkit available from
teachbacktraining.org, the American Heart Association, peer-reviewed evidence based
guidelines, and from consultation from expert cardiology clinicians vested in improving
nonadherence. The educational modules were delivered by use of a PowerPoint
presentation, informational handouts, and role-playing exercises, followed by group
discussion.
Anonymous pre and post participation surveys in Likert-type format were
administered to evaluate the efficacy of the intervention in enhancing knowledge
regarding the delivery of health information to patients, the medication nonadherence
problem, and the overall quality of the presentation. The survey consisted of ten
questions with total scores ranges from ten to forty. The ten questions assessed the
clinicians understanding of health literacy issues, and their confidence and perceived
ability to communicate with patients regarding the barriers and solutions to address
medication adherence.
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Upon completions of the four educational sessions, the pre and post surveys were
analyzed using descriptive statistics to assess the impact of the educational module on the
clinicians understanding and confidence in addressing the problem of medication
adherence.

Enhancements and Inhibitors to Meeting the Project Objectives
The implementation of this project coincided with the hospital wide goal of
improving the Hospital Consumer Assessment of Healthcare Providers and Systems
(HCAHPS) scores regarding medication education. Additionally, the project was relevant
to the institutional goals of reducing readmission rates for myocardial infarctions, with
financial incentives related to the readmission reduction program (HRRP) established by
the Affordable Care Act (Medicare, 2016). These two institutional wide goals assisted in
gaining buy-in from administrative and clinical education coordinators.
The practice council on the cardiology unit where the project was implemented
also initiated a medication information patient handout and an “Always Ask” project
within the same time period that this project was implemented. The “Always Ask”
project involves prompting patients via the use of in-room posters to ask about the
purpose of new medications and their possible side effects. These concerted efforts
complemented the concepts of the teach-back method and the health literacy goals of the
project.
Inhibitors to implementing the project objectives included the variability and
availability of participants for the presentation due to the nature of the workflow and
staffing levels on any given day. Residents and interns also rotate through the cardiology
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service therefore presenting a challenge to maintain a level of consistency regarding the
manner in which medication education is delivered. To reduce these inhibitory factors, a
poster and a permanent TV screen PowerPoint will offer the ability to display the core
principals of the teach-back method and educate new staff on the problem of medication
adherence. Finally, knowledge alone does not guarantee behavior change; attitudes and
beliefs need to change as well to increase the likelihood of shifting behavior.
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CHAPTER IV: RESULTS
Evaluation
The anonymous pre and post survey in Likert style administered during the
presentations consisted of ten questions with four possible responses. Scores from 1 to 4
were assigned to each possible response with a score of 1 corresponding to strongly
disagree, 2 with disagree, 3 with agree, and 4 with strongly agree. Therefore, total
individual survey scores could range from 10 to 40. To allow for accurate global survey
conclusions, scores on four of the questions were reversed to allow for accurate
comparisons. Table 1 lists the individual questions, their associated range, means pre and
post-survey, difference in means, and the total means. Questions 1, 2, 4, and 10 listed in
table 1 are reverse scored, therefore a trend toward increased numbers on any of the
questions represents an increase in understanding or confidence.
A total of 25 pre and post surveys were completed following the four
presentations. Of the total participants, 21 were staff nurses representing approximately
25% of the eligible staff nurses, and 4 were resident internal medicine physicians that
were currently rotating through the inpatient cardiology service. The mean score for all
questions on the pre-survey, including the reverse-scored items, was 29.6. The mean
score of all post-survey questions was 33. All ten questions demonstrated an
improvement as measured by the post-survey. Although the sample size is too small to
conclude any statistical significance between the pre and post-test survey scores, the
clinician knowledge and confidence scores for this sample improved following the
educational presentation and accompanied discussion.
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Table 1: Range and Mean of Scored Questionnaires

Survey Questions

Range
PreSurvey

Mean
Score
PreSurvey

Range
PostSurvey

Mean
Score
PostSurvey

Difference
in Means

1. I am uncomfortable talking to
patients about barriers to medication
adherence. *REVERSE SCORED*

1-4

2.7

2-4

3.0

0.3

2. Most hospitalized patients
understand why they need to take
their new medications. *REVERSE
SCORED*

2-4

3.0

3-4

3.3

0.3

3. I am confident in my ability to
assess my patients understanding of
their disease and medications.

1-4

2.4

3-4

3.2

0.8

4. Patients face few barriers to being
able to take their medications as
directed. *REVERSE SCORED*

1-4

2.8

2-4

3.4

0.6

5. I understand the value of teachback in patient education.

3-4

3.4

3-4

3.6

0.2

6. I feel confident in my ability to
use teach-back during patient
education.

2-4

3.1

2-4

3.3

0.2

7. I feel confident in my ability to
use plain language instead of
medical terms.

2-4

3.1

2-4

3.3

0.2

8. I feel confident in my ability to
discuss the purpose of the common
cardiovascular medications with
individuals with heart disease.

2-4

3.1

3-4

3.4

0.3

9 I feel confident in my ability to
assist patients with common
medication adherence barriers.

1-3

2.7

2-4

2.9

0.2

10. Patients tend to remember and
understand most of the information
presented to them during an
encounter. *REVERSE SCORED*

2-4

3.3

3-4

3.6

0.3

Totals

29.6

33.0
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Discussion
The survey results highlighted some of the foundational barriers to medication
adherence while also demonstrating that brief educational sessions may impact
communication related to improving adherence. The results of this project support the
existing literature and the widespread understanding that patient health literacy remains a
significant barrier to health outcomes (Bosworth et al., 2011). Question 2 asks: Most
hospitalized patients understand why they need to take their new medications. Question
10 asked: Patients tend to remember and understand most of the information presented to
them during an encounter. Mean pre and post survey scores for both questions
aggregated between the “disagree” and “strongly disagree” responses, indicating that
most clinicians are aware of the health literacy problems encountered by most patients.
The communication related difficulties are likely exacerbated by the necessity to educate
and motivate patients about complex cardioprotective medication regimens in a relatively
short time period. Additionally, patients experiencing great stress and denial with regard
to their acute cardiovascular event may also inhibit inpatient education effectiveness and
efficiency. However, the need to provide education regarding discharge medications and
treatment plans is imperative, especially in the immediate period following discharge for
a cardiovascular related event (Ho P, Lambert-Kerzner A, Carey EP, & et al, 2014) .
The results also demonstrate that education about medication nonadherence
awareness and training related to developing clinician-patient communication techniques
can increase knowledge and confidence useful in addressing adherence. As Glynn &
Fahey, (2011) demonstrated in their systematic analysis of adherence interventions,
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patient health education is known to have a positive effect on adherence. Survey
questions inquiring about the clinician’s confidence in assessing patient knowledge and
the clinicians own understanding of medication nonadherence as demonstrated in
questions 1, 3, and 4 demonstrated some of the greatest ranges in results. This range is
consistent with the literature on the subject regarding the lack of commonplace adherence
assessments or awareness of the extent of the problem. The results of the survey and
presentations also revealed an inconsistent and common misunderstanding of the
medication’s role for cardioprotection (Ho et al., 2009). Question 3 specifically asks: I
am confident in my ability to assess my patients understanding of their disease and
medications. The pre and post survey results for this question demonstrated the greatest
increase in score of all questions, with a pre-survey score of 2.4 increasing to a postsurvey score of 3.2. This question correlates well with the overall objective of the
presentation and the inclusiveness of the teach-back tool in providing an evidenced based
method for delivering and assessing patient education. Question 8, which asked: I feel
confident in my ability to discuss the purpose of the common cardiovascular medications
with individuals with heart disease, scored favorably on both the pre and post surveys,
however scores did improve after the presentation. This slight increase correlates with the
discussions that ensued after the presentations that demonstrated an incomplete
understanding of the evidence for and mechanism of action of each of the core
cardiovascular medications. These findings support the notion that clinician comfort and
knowledge regarding the purpose of the common cardiovascular medications benefit
from periodic education (Santo et al., 2016).
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Implications for Practice, Education, and Research
Understanding the continued need for clinician education to improve patient
encounters and advance patient health literacy has implications for research, education,
and clinical practice. Interventions such as clinician oriented education support the
published research regarding interventions that are proven to improve medication
adherence. Strategies to optimize educational content and delivery are needed to
maximize clinician contact time and the incorporation of new knowledge into practice.
Educational delivery models that account for limited educational opportunities, influxes
of new clinicians, and content adaptability are needed to sustain awareness and skills.
Nonadherence is a problem that is extensive yet rarely assessed or addressed.
Incorporating standardized medication adherence assessments and increasing the
awareness of the problem is needed. Opportunities exist to research, develop, and
incorporate adherence assessment mechanisms into routine practice through micro and
macro scale campaigns, common intake assessment tools, electronic health records, and
core educational content.
Nonadherence is not unique to cardiovascular settings. Medications are the
primary instrument used to prevent and manage chronic disease, yet despite their known
benefit and importance, adherence remains a challenge to clinicians and patients. The
information presented in this project and the knowledge gained can be translated to
settings beyond the inpatient cardiology specialty. Any setting that not only provides care
to patients prescribed chronic medications, but also understands the value of making the
patient a knowledgeable and active partner in their health will benefit from the
information garnered from this project.
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Limitations
Limitations of this project included a relatively small homogenous sample size
consisting primarily of female inpatient registered nurses. Delivery of the educational
module was limited by the clinician availability and inability to disengage from patient
care or work related distractions due to the presentation timing occurring during
scheduled shifts on the unit itself. The project occurred at a single point in time with
limited ability to measure content retention and application. Post-assessments of the
content at a later point in time would have provided a better understanding about whether
the presentation reformed clinician practice.

Conclusion
This project has demonstrated the potential benefits that an education based
intervention can have on increasing the knowledge, confidence, and skills needed to
impact medication nonadherence and optimize cardiac outcomes. The research and
current state of understanding reveals that medication nonadherence to each and all
guideline-recommended post myocardial infarction prevention medications is associated
with an increased risk of future cardiovascular events and mortality. Although
medications are the cornerstone of heart disease management and prevention,
nonadherence is widespread yet poorly understood or addressed. The review of the
literature has demonstrated that interventions to improve medication adherence, whether
complex multi-factorial in design, or simple one-component interventions, all have the
potential to improve adherence. The results of this project suggest that educational based
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interventions to increase awareness of the nonadherence problem while also
incorporating simple low cost solutions such as the teach-back method may be an
effective approach to improve adherence and outcomes related to cardiac events and
other chronic illnesses. Efforts to improve the health literacy of all patients while striving
to make them engaged partners in their health care may be one of the most important
goals to advance individual health outcomes as well as global health systems
improvement.
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Appendix A
Anonymous Medication Adherence Questionnaire
Question #
1. I am uncomfortable talking to patients about
barriers to medication adherence.

2. Most hospitalized patients understand why they
need to take their new medications.
3. I am confident in my ability to assess my patients
understanding of their disease and medications.
4. Patients face few barriers to being able to take
their medications as directed.

5. I understand the value of teach-back in patient
education.

6. I feel confident in my ability to use teach-back
during patient education.

7. I feel confident in my ability to use plain language
instead of medical terms.

8. I feel confident in my ability to discuss the purpose
of the common cardiovascular medications with
individuals with heart disease.

9 I feel confident in my ability to assist patients with
common medication adherence barriers.
10. Patients tend to remember and understand
most of the information presented to them during an
encounter.

Strongly
Disagree

Disagree

Agree

Strongly
Agree
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